Filter posts

BIO Chimes In: TC Heartland LLC v. Kraft Food Brands Group LLC (Supreme Court)

This is part two of a three part series on BIO’s recently submitted amicus briefs in cases …

PTAB, IPRs and Uncertainty in the Patent System

The topic of inter partes reviews (IPRs) has dominated conversation in patent circles for the …

BIO Releases Points to Consider on Truthful and Non-Misleading Product Communication

Today, BIO releases Points to Consider on Truthful and Non-Misleading Product Communication. This document advances the dialogue …

Orphan Drug Tax Credit is Crucial to Rare Disease R&D

The term “rare disease” may be misleading: to be “rare” a disease must effect fewer …

IP Sessions at the 2015 BIO International Convention

This year’s BIO International Convention will be host to educational sessions on the latest issues …

BIO Chair Testifies Before Senate

BIO’s Chair and CEO of GlycoMimetics, Rachel King, testified before the Senate Committee on Small …

How Industry Rates Interactions with the FDA

Kicking off day one of the BIO CEO & Investor Conference in New York City, …

Patently Biotech’s Top Articles of 2014

It’s been a whirlwind year for IP. From international trade negotiations, to revised PTO guidelines …

PTO Patent Examinations in the wake of Mayo and Myriad

Biotech patent applicants are finding themselves in uncharted waters.   After the Supreme Court’s decisions …

For 2014 LBS - Early Bird Rates Plus a Complimentary Registration!

BIO Livestock Biotech Summit September 16–18, 2014 in Sioux Falls, South Dakota We know that …